Discovery Funding Opportunities
NINR Clinical Trial Planning Grant (R34)
Due Date: 02-24-2017
This FOA encourages applications that propose the complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The application should propose the developmental work to be performed that would enhance the probability of reaching definitive outcomes in a clinical trial.
Diabetes Research Centers (P30)
Due Date: 02-28-2017
This FOA invites applications for Diabetes Research Centers that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases.
NIH/NIDDK: Assay Development & Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK (R01)
The goal of this FOA is to develop, validate, or conduct a screen using a novel assay to identify therapeutic or imaging agents relevant to health related outcomes of interest to the NIDDK. It is expected that state of the art measures of basic cellular processes or molecular events that are key mediators of disease pathogenesis are incorporated into these novel assays.
T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44)
Due Date: 02-28-2017
For the purposes of this FOA, T2 translational research on aging involves the development or evaluation of methods for disseminating (1) results from clinical studies into everyday clinical practice and health decision-making in geriatric medicine, (2) results from large scale behavioral and community interventions into practice in community organizations, workplaces, and public institutions, and (3) development of new technologies for enhancing research productivity in aging research.
Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01)
Due Date: 03-01-2017
The purpose of this FOA is to stimulate research in the area of PDAC microenvironment with the ultimate goal of understanding the interaction between tumors and the microenvironment. The plan is to design new immunotherapy and combination interventions that would accommodate and build on the distinct characteristics of this interaction.
Academic-Industrial Partnerships to Translate & Validate in vivo Cancer Imaging Systems (R01)
Due Date: 03-01-2017
The purpose of this FOA is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status.
Winship Invest$ Prostate Cancer Research Pilot Grant
Due Date: 03-01-2017
Thanks to generous gifts from the Senior Men¿s Golf Association of Dunwoody Country Club and the Club¿s John Kauffman Prostate Cancer Golf Event, Winship Cancer Institute is pleased to announce a prostate cancer research pilot grant opportunity for Winship investigators. Innovative proposals that address prostate cancer research including but not limited to basic or translational research, investigator initiated clinical trials (related IRB submission must be either in review or approved), health disparities, imaging, survivorship or quality of life will be considered for funding.
NIH/NIAID/NIA: Investigator Initiated Extended Clinical Trial (R01)
Due Date: 03-07-2017
This FOA invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of six or seven years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs.
Opportunity to Sequence Pediatric Cohorts through the Kids First Program
Due Date: 03-07-2017
Kids First is soliciting applications (PAR-17-063) to identify samples for whole genome sequencing that will help to elucidate the genetic contribution to childhood cancers and structural birth defects. The Common Fund¿s Gabriella Miller Kids First Pediatric Research (Kids First) program is developing a data resource for the pediatric research community of clinical and genetic sequence data that will allow scientists to identify genetic pathways that underlie childhood cancer and structural birth defects and to explore whether shared genetic pathways exist between these conditions. Register for a pre-application webinar by Kids First program staff on January 23, from 3:00-4:00 p.m
Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)
Due Date: 03-03-2017
The purpose of this FOA is to invite applications to stimulate innovative collaborative research in the NCATS¿ Clinical and Translational Science Award (CTSA) consortium.
NSF BIGDATA Solicitation 2017
Due Date: 03-15-2017
The BIGDATA program seeks novel approaches in computer science, statistics, computational science, and mathematics, along with innovative applications in domain science.
Southeast Center for Integrated Metabolomics (SECIM): 2017 Pilot & Feasibility Project Awards
Due Date: 03-16-2017
The SECIM invites applications for the 2017 Pilot & Feasibility Project Awards, which provide up to $50,000 per award in support of 12-month metabolomics projects. The purpose of the awards is to enhance metabolomics research by providing support for investigators new to the metabolomics field, the development of new teams and partnerships, and high-risk/high-impact research.
NINDS Exploratory Clinical Trials (R01)
Due Date: 03-21-2017
The purpose of this FOA is to encourage grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies.
National Institute of Neurological Disorders & Stroke Research Program Award (R35)
Due Date: 03-21-2017
The purpose of the award is to provide longer-term support and increased flexibility to Program Directors/Principal Investigators (PIs) whose outstanding records of research achievement demonstrate their ability to make major contributions to neuroscience.
Competitive Collaborative Projects for Human Islet Biology (UC4)
Due Date: 03-23-2017
This FOA solicits applications for collaborative research projects that will enhance the goals of the Human Islet Research Network (HIRN). The HIRN is a collaborative program consisting of multiple related but distinct research consortia focused around two common goals: increasing our understanding of how human beta cells are lost in Type 1 Diabetes, and finding innovative strategies to protect or replace functional beta cell mass in diabetic patients.
The McKnight Endowment Fund for Neuroscience: 2018 Memory & Cognitive Disorders Award
Due Date: 03-27-2017
The fund supports innovative research designed to bring science closer to the day when diseases of the brain can be accurately diagnosed, prevented, and treated. To this end, the McKnight Memory and Cognitive Disorders Award assists scientists working to apply the knowledge achieved through basic research to human brain disorders that affect memory or cognition.
Exploratory CTSA Collaborative Innovation Awards (R21 Supplement)
Due Date: 03-29-2017
The purpose of This FOA is to support highly innovative, exploratory, collaborative research projects in the NCATS¿ Clinical and Translational Science Award (CTSA) program, with the goal of assessing utility and feasibility of proposed innovation(s). The opportunity offers $275K over two years. The opportunity is broad ¿ from microbiome to building a better trial.
National Lupus Outreach & Clinical Trial Education Program
Due Date: 03-31-2017
The National Lupus Outreach and Clinical Trial Education Program (¿Lupus Program¿) seeks to reduce lupus related health disparities among racial and ethnic minority and/or disadvantaged populations disproportionately affected by this disease by: implementing and assessing a national health education program on lupus; and developing, piloting, and assessing provider education interventions designed to increase minority participation in clinical trials for lupus and developing a plan for broader implementation of such interventions.
HHS Partnerships to Achieve Health Equity
Due Date: 03-31-2017
The Partnership to Achieve Health Equity (PAHE) program will support partnerships that involve an organization with a nationwide reach, focus or impact, and which includes addressing social determinants of health to achieve health equity for racial and ethnic minority and/or disadvantaged populations, through programs which: (1) Improve access to and utilization of care by racial and ethnic minority and/or disadvantaged populations; (2) Test models of disease management including health promotion and disease prevention for individuals with multiple chronic conditions that disparately affect racial and ethnic minorities and affect morbidity.
Pediatric Research Alliance 2017 Pilots: Request for Applications
Due Date: 04-03-2017
The Pediatric Research Alliance announces the availability of 2017 pediatric research pilot funding for the Pediatric Research Center Pilot Awards and the Pediatric Research Fusion Pilot Awards to stimulate new research projects, build new collaborations, and increase extramural funding for pediatric research. Proposals should be aimed towards generating preliminary data for subsequent extramural grant applications.
American Diabetes Association: Innovative Clinical or Translational Science Award (ICTS)
Due Date: 04-17-2017
The program funds research with novel and innovative hypotheses in any area relevant to the etiology or pathophysiology of diabetes and its complications that hold significant promise for advancing the prevention, cure or treatment of diabetes. Basic, clinical, translational, and epidemiological or health services research approaches are encouraged
Pfizer CTI Call for Proposals
Due Date: 04-28-2017
Pfizer¿s CTI network includes partners from leading academic medical centers, foundations, and NIH. The CTI goal is to identify biotherapeutic molecules and speed research and drug development from validated target to proof-of-mechanism in the clinic. Advantages to Collaborating with CTI A cooperative research and development agreement (CRADA) collaboration with CTI includes access to Pfizer¿s drug development expertise, publishing rights and resources. It also may provide funding to carry out the collaborative work at the NIH Intramural Research Program principal investigator¿s laboratory.
March of Dimes 2018 Research Program
Due Date: 04-30-2017
MOD invites all qualified scientists with faculty appointments or the equivalent, at universities, hospitals and research institutions (not for profit or profit), to submit applications for research grants relevant to the mission of the March of Dimes, to improve the health of babies by preventing birth defects, premature birth, and infant mortality.
W. M. Keck Foundation: Request for Pre-application Abstracts
Due Date: 05-01-2017
The Keck Foundation Research Program supports projects in medical research and science and engineering that are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field. Both Senior and Early Career investigators are encouraged to apply.
Shared Instrumentation Grant (SIG) Program (S10)
Due Date: 05-31-2017
The program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000.
High-End Instrumentation (HEI) Grant Program (S10)
Due Date: 05-31-2017
The program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,001.
Center of Excellence for Research on Complementary & Integrative Health (P01)
This FOA encourages the submission of applications that requires multi-project, synergistic collaboration between outstanding scientists that blends multiple research approaches by multi-disciplinary research teams.
NIH Health Care Systems Research Collaboratory: Demonstration Projects for Pragmatic Clinical Trials
Due Date: 06-02-2017
Trials must be conducted across two or more health care systems and must be conducted as part of the NIH HCS Research Collaboratory supported through the NIH Common Fund. Any ACTSI investigators interested in applying should contact Lance Waller to discuss biostatistical support.
Transformative High Resolution Cryoelectron Microscopy Program: Support for the Creation of National Centers of Cryoelectron Microscopy
Due Date: 06-30-2017
The NIH Common Fund program in Transformative High Resolution Cryoelectron Microscopy (cryoEM) aims to accelerate and broaden the impact of recent dramatic advances in cryoEM technology on the biomedical research community. The centers will provide access to state-of-the-art equipment, technical support, and cross-training for the production and analysis of high-resolution data.
RJWF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health
Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Their mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.
Are you frustrated with a device that you use? Is there a clinical process you see that needs improvement? Do you have a brilliant idea for a system, device, or program that would make life better `For the Kids¿? Quick Wins is a funding program put in place to provide rapid solutions to unmet clinical and business needs at Children¿s Healthcare of Atlanta.